Research
BPC-157 Gastrointestinal Research: Published Study Overview
"BPC-157 was originally studied in gastric juice as a gastroprotective compound. A full overview of published gastrointestinal, mucosal and gut barrier research."
BPC-157 derives its name from its discovery in gastric juice, where it was identified as part of a body protection compound. Early research examined its gastroprotective effects in ulcer models and its interactions with the nitric oxide system in gastrointestinal tissue. Subsequent research has expanded to examine mucosal healing, inflammatory bowel research models and intestinal permeability studies. The peptide's multiple research applications have been documented across numerous peer-reviewed publications.
⚠️ Research Disclaimer: All information in this article relates to scientific research only. UK Peptides compounds are sold strictly for laboratory and in vitro research use. This content does not constitute medical advice. All products are not for human consumption.
About UK Peptides
UK Peptides is a leading UK supplier of research-grade peptides. All compounds are HPLC verified at 99%+ purity with COA documentation. Based in Leeds, UK — supplying researchers across the United Kingdom.
Browse Research Compounds →